Effect of high-dose atorvastatin therapy accompanied by discontinuation of cholesterol-rich diet on color-doppler ultrasonography parameters of atherosclerotic carotid artery

Mehrad, H.; Mokhtari‐Dizaji, Manijhe

doi:10.1016/j.atherosclerosis.2017.06.797

Cited by 1 publication

(2 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Studies abroad have reported that atorvastatin have the effect of preventing AKI, but there are few reports in China. 16,17 This study investigated the preventive effect of intensive dose of atorvastatin and conventional dose of atorvastatin on CI-AKI after CT perfusion and showed that the intensive dose of atorvastatin can significantly improve CI-AKI through reducing lipid, inflammation, and the incidence of CI-AKI patients.…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

The preventive effects of different doses of atorvastatin on contrast‐induced acute kidney injury after CT perfusion

Yan

Gao

Yang

et al. 2022

Clinical Laboratory Analysis

View full text Add to dashboard Cite

Background: Contrast-induced acute kidney injury (CI-AKI) is a severe complication among patients receiving intravascular contrast media. The purpose of this study was to investigate the preventive effects of pretreatment of atorvastatin at intensive doses on CI-AKI after computed tomography (CT) perfusion. Methods:The levels of serum creatinine (SCR), blood urea nitrogen (BUN), Cystatin C (CysC), estimated glomerular filtration rate (eGFR), high-sensitivity C-reactive protein (hs-CRP), and interleukin-6 (IL-6) in patients were compared between the observation group receiving 40 mg/kg atorvastatin and the control group receiving 20 mg/ kg atorvastatin before and 72 h after CT examination. In addition, the incidence of CI-AKI was recorded.Results: Compared with the control group, the incidence of renal injury in the observation group was significantly reduced, from 8% to 2% (χ 2 = 6.62, p = 0.010). In addition, there was no notable difference in the levels of Scr, BUN, CysC, hs-CRP, and IL-6 before CT examination between two groups (p > 0.05). The levels of SCR, BUN, CysC, hs-CRP, and IL-6 were increased, while the levels of eGFR were decreased in the control group at 72 h after CT examination (p < 0.05). At 72 h after CT enhancement, the levels of BUN, CysC, and hs-CRP were prominently increased in the observation group (p < 0.05), while SCR, eGFR, and IL-6 did not change (p > 0.05). Compared with the control group, the levels of SCR, BUN, CysC, eGFR, hs-CRP, and IL-6 in the observation group were significantly decreased at 72 h after CT examination (p < 0.05). Conclusion:Intensive dose of atorvastatin pretreatment can prevent CI-AKI undergoing CT perfusion through lowering inflammation as well as renal function indexes SCR, CysC, BUN, and eGFR.

show abstract

Section: Discussionmentioning

confidence: 99%

“…Therefore, the incidence of CI‐AKI has been greatly increased, which has attracted the attention of scholars around the world. Studies abroad have reported that atorvastatin have the effect of preventing AKI, but there are few reports in China 16,17 …”

Section: Discussionmentioning

confidence: 99%